| 产品名称： | Chlamydophila pneumoniae |
|---|---|
| 商品货号： | TS210451 |
| Classification： | Chlamydiaceae, Chlamydophila |
| Deposited As： | Chlamydia pneumoniae |
| Agent： | Chlamydophila pneumoniae |
| Strain： | AR-39 |
| Applications： | Respiratory research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 1 mL per vial |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Activities with high potential for aerosol production require Biosafety Level 3 facilities and practices. The inclusions are iodine stain negative (contain no glycogen). The TWAR strains of Chlamydia are named after TW183 and AR39. This material is cited in a U.S. and/or other Patent Application and may not be used to infringe the patent claims. |
| Effect on Host： | Intracellular inclusion bodies visualized by fluorescent staining with genus or species specific monoclonal antibodies or Giemsa. |
| Recommended Host： | HEp-2 (ATCC® CCL-23™)
|
| Growth Conditions： | Temperature: 35°C Recommendations for Infection: Plate cells 16-24 hours prior to infection and infect when cultures are 80-90% confluent. Disrupt cells in the inoculum by sonicating for 20 seconds at approximately 240W or by adding glass beads to the inoculum and vortex mixing. Remove medium and inoculate with disrupted material. Centrifuge at 2,300 - 2,400 x g at 20°C for 1 hour. End adsorption by adding agent growth medium. Incubation: 3 days at 35°C in a humidified 5% CO2 atmosphere. |
| Name of Depositor： | Washington Research Foundation |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Special Collection： | NCRR Contract |
| Source： | Throat of university student with acute pharyngitis, Seattle, WA, 1983 |
| References： | Grayston JT, et al. Chlamydia pnemoniae sp. nov. for Chlamydia sp. Strain TWAR. Int. J. Syst. Bacteriol. 39:88-90, 1989. Kuo CC, Grayston JT. Chlamydia spp. strain TWAR: A newly recognized organism associated with atypical pneumonia and other respiratory infections. Clin. Microbiol. Newsletter 10: 137-140, 1988. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Chlamydophila pneumoniae |
|---|---|
| 商品货号： | TS210451 |
| Classification： | Chlamydiaceae, Chlamydophila |
| Deposited As： | Chlamydia pneumoniae |
| Agent： | Chlamydophila pneumoniae |
| Strain： | AR-39 |
| Applications： | Respiratory research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 1 mL per vial |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Activities with high potential for aerosol production require Biosafety Level 3 facilities and practices. The inclusions are iodine stain negative (contain no glycogen). The TWAR strains of Chlamydia are named after TW183 and AR39. This material is cited in a U.S. and/or other Patent Application and may not be used to infringe the patent claims. |
| Effect on Host： | Intracellular inclusion bodies visualized by fluorescent staining with genus or species specific monoclonal antibodies or Giemsa. |
| Recommended Host： | HEp-2 (ATCC® CCL-23™)
|
| Growth Conditions： | Temperature: 35°C Recommendations for Infection: Plate cells 16-24 hours prior to infection and infect when cultures are 80-90% confluent. Disrupt cells in the inoculum by sonicating for 20 seconds at approximately 240W or by adding glass beads to the inoculum and vortex mixing. Remove medium and inoculate with disrupted material. Centrifuge at 2,300 - 2,400 x g at 20°C for 1 hour. End adsorption by adding agent growth medium. Incubation: 3 days at 35°C in a humidified 5% CO2 atmosphere. |
| Name of Depositor： | Washington Research Foundation |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Special Collection： | NCRR Contract |
| Source： | Throat of university student with acute pharyngitis, Seattle, WA, 1983 |
| References： | Grayston JT, et al. Chlamydia pnemoniae sp. nov. for Chlamydia sp. Strain TWAR. Int. J. Syst. Bacteriol. 39:88-90, 1989. Kuo CC, Grayston JT. Chlamydia spp. strain TWAR: A newly recognized organism associated with atypical pneumonia and other respiratory infections. Clin. Microbiol. Newsletter 10: 137-140, 1988. |
